Home
Medicines
Companies
COVID-19
Active Ingredients
Advanced Search
Adverse Event Reporting
Login
Search Medicine Database
Home
Medicines
Companies
COVID-19
More
expand_more
Login
menu
Home
Active Ingredients
Upadacitinib
Upadacitinib
Medicine
Status
PIL
SPC
XPIL
Legal Category
Active Ingredient(s)
Company
RINVOQ 15 mg prolonged-release tablets
Updated
PIL
21/12/21
SPC
21/12/21
No
A
Upadacitinib
AbbVie Limited
RINVOQ 30 mg prolonged-release tablets
Updated
PIL
21/12/21
SPC
21/12/21
No
A
Upadacitinib
AbbVie Limited
Documents associated with this medicine were updated in the last 30 days.
Date of Update on Medicines.ie
Product subject to medical prescription which may not be renewed (A)
